Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic Schizophrenia
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
Lurasidone HCl is a compound being developed for the treatment of schizophrenia. This
clinical study is designed to test the hypothesis that lurasidone is effective, tolerable,
and safe as compared with quetiapine XR long term among schizophrenic outpatients with
chronic schizophrenia.